NASDAQ: SLGL - Sol-Gel Technologies Ltd.

Altı ay boyunca karlılık: -28.67%
Temettü getirisi: 0.00%
Sektör: Healthcare

Promosyon programı Sol-Gel Technologies Ltd.

Gelişmiş program Basit grafik
Financial Markets by TradingView

Şirket hakkında Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on identifying, developing, and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel.

daha fazla ayrıntı
The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has completed Phase III clinical trials for the treatment of acne vulgaris; Epsolay, a once-daily topical cream that has completed Phase III clinical trials for the treatment of papulopustular rosacea; SGT-210, which is in Phase I clinical trial for the treatment of palmoplantar keratoderma; SGT-610, a rare disease for the treatment of Gorlin Syndrome which has completed Phase II clinical trials; and Erlotinib and Tapinarof to treat other rare skin indications. It is also involved in the development of generic topical dermatological drug products. The company has collaboration with Perrigo. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.
Karşılaştırma listesine ekle
İzleme listesine ekle
Portföye ekle
Fiyat bildirimi ekle

IPO date 2018-01-23
ISIN IL0011417206
Industry Pharmaceuticals
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.sol-gel.com
Цена ао 0.559
Günlük fiyat değişimi: +11.55% (0.4284)
Haftalık fiyat değişimi: +8.61% (0.44)
Aylık fiyat değişimi: -14.06% (0.5561)
3 ayda fiyat değişimi: -62.07% (1.26)
Altı ayda fiyat değişimi: -28.67% (0.67)
Yıllık fiyat değişimi: -44.46% (0.8605)
3 yılda fiyat değişimi: -92.94% (6.77)
5 yılda fiyat değişimi: -91.87% (5.88)
Yılbaşından bu yana fiyat değişimi: -71.04% (1.65)
Tüm parametreler

Hafife alma

İsim Anlam Seviye
P/S 20.92 1
P/BV 0.8411 9
P/E 0 0
EV/EBITDA -0.9182 0
Toplam: 4.63

Yeterlik

İsim Anlam Seviye
ROA, % -60.15 0
ROE, % -70.48 0
Toplam: 0

Temettüler

İsim Anlam Seviye
Div yield, % 0 0
DSI 0 0
Toplam: 0

Görev

İsim Anlam Seviye
Debt/EBITDA -0.057 10
Toplam: 10

Büyüme dürtüsü

İsim Anlam Seviye
karlılık Revenue, % -93.21 0
karlılık Ebitda, % 15.39 3
karlılık EPS, % -20.18 0
Toplam: 1
Daha fazla ayrıntı

Kurumlar Hacim Paylaşmak, %
Phoenix Holdings Ltd. 2574922 9.24
Armistice Capital, LLC 2135000 7.66
Migdal Insurance & Financial Holdings Ltd. 1227548 4.41
Harel Insurance Investments & Financial Services Ltd. 920333 3.3
Kingdon Capital Management LLC 674923 2.42
Yelin Lapidot Holdings Management Ltd. 229178 0.82
Raymond James Financial Services Advisors, Inc. 43102 0.15
Raymond James & Associates, Inc. 30915 0.11
Morgan Stanley 28935 0.1
Citadel Advisors Llc 17259 0.06



Süpervizör İş unvanı Ödeme Doğum yılı
Dr. Alon Seri-Levy Co-Founder, CEO & Director 411k 1961 (64 yıl)
Mr. Gilad Mamlok Advisor 367k 1968 (57 yıllar)
Dr. Itzik Yosef Chief Operating Officer 236k 1976 (49 yıllar)
Mr. Moshe Arkin Executive Chairman of the Board N/A 1953 (72 yıl)
Prof. David Avnir Co-Founder N/A
Ms. Tamar Fishman Jutkowitz VP & General Counsel N/A 1976 (49 yıllar)
Dr. Karine Neimann VP of Projects & Planning and Chief Chemist N/A 1971 (54 yıl)
Mr. Eyal Ben-Or Chief Financial Officer

Adres: Israel, Ness Ziona, 7 Golda Meir Street - Google haritalarda aç, Yandex haritalarını aç
Web sitesi: https://www.sol-gel.com